Expedition Therapeutics $165M Sales Trigger
Expedition Therapeutics just closed a $165M Series A. Time to pitch CTMS. Grab CEO Yi Larson’s email, core pain points & next-touch checklist to close fast.
Published on
Do not index
Do not index
🚀 Battle Card: Expedition Therapeutics
Quick trigger:
👤 Decision Maker in the News
- Yi Larson, CEO 📧 <yi.larson@expeditiontx.com>
💡 Why It Matters
- Fresh capital means ramping up clinical development and in-licensing processes fast to stay ahead. → Source
🎯 Core Pain Point
- Scaling complex clinical operations for EXPD-101 across global sites
- Meeting regulatory compliance in a high-stakes, post-Series A environment
💰 What to Pitch
- Primary: Clinical Trial Management System → Accelerate IND filings and patient enrollment
- Expansion: Regulatory Compliance & Data Analytics Suite → Streamline submissions and reduce audit risks
🗺️ Quick Context
- HQ: San Francisco, CA
- Employees: ≈ 150
- Rev: ≈ $0 (pre-revenue)
🤼 Competitive Intel
Which other vendors you’ll probably face to win Expedition Therapeutics’s business.
- Medidata (medidata.com) — CTMS / eCOA
- Unique edge: Deep pharma integration
- Evaluated by Head of Clinical Ops
- Veeva Systems (veeva.com) — Vault CTMS / QMS
- Unique edge: End-to-end regulatory vault
- Evaluated by VP Regulatory Affairs
- Oracle Health Sciences (oracle.com) — Integrated trial solutions
- Unique edge: Robust global scalability
- Evaluated by CIO for data security
- Benchling (benchling.com) — R&D informatics
- Unique edge: Lab-to-clinic data sync
- Evaluated by Head of Translational Science
- IQVIA (iqvia.com) — CRO / analytics
- Unique edge: Real-world evidence capabilities
- Evaluated by VP Strategy
✅ Do-Now Checklist
Reference the $165M Series A as the Expedition Therapeutics sales trigger in your outreach
Schedule personalized demos of CTMS and regulatory suite (Day 3 & Day 10)
Next Step
Get these Expedition Therapeutics sales trigger insights—no fluff, all pipeline.
Subscribe to NewsletterForLeads
🧠 Copy My Prompt for Personalized Cold Outreach
────────────────────────────
✏️ YOUR COMPANY
────────────────────────────
OUR_COMPANY = ❑<your company>❑
OFFER_BRIEF = ❑Clinical Trial Management System to accelerate IND filings and patient enrollment❑
PROOF_METRIC = ❑≈ TBD❑
CTA_STYLE = ❑quick_call❑
TONE = ❑friendly❑
────────────────────────────
📌 TARGET COMPANY
────────────────────────────
NAME = Yi
COMPANY = Expedition Therapeutics
DEPT = Clinical Operations
SIZE = 150
BOTTLENECK = scaling complex clinical operations
EVENT = Oversubscribed $165M Series A Financing
DETAIL = Fresh capital raises
PAIN = scaling complex clinical operations
SRC = https://vcnewsdaily.com/expedition-therapeutics/venture-capital-funding/xrgmjmgjjm
SIM_CO = ≈ TBD
WIN_METRIC = ≈ TBD
NEXT_SIZE = ≈ TBD
EMP_EST = ≈ 150
REV_EST = ≈ $0M
────────────────────────
TASK FOR CHATGPT
────────────────────────
Role: “NewsletterForLeads SDR-Assist”
Validate any ≈ guesses via SRC
EMAIL (keep breaks):
Subject: 150-person Clinical Operations
Yi—noticed your Clinical Operations team is ≈ 150.
That’s when scaling complex clinical operations slows growth.
We helped ≈ TBD fix this with Clinical Trial Management System to accelerate IND filings and patient enrollment.
Result: ≈ TBD.
Quick call?
PS—next bottleneck hits ≈ TBD.
DM ≤45 words, TONE:
Saw your post about Fresh capital raises — scaling complex clinical operations.
Clinical Trial Management System to accelerate IND filings and patient enrollment. ≈ TBD.
Quick chat?